Serum levels of type IIA procollagen amino terminal propeptide (PIIANP) are decreased in patients with knee osteoarthritis and rheumatoid arthritis.
- 1 June 2004
- journal article
- research article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 12 (6) , 440-447
- https://doi.org/10.1016/j.joca.2004.02.004
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritisArthritis & Rheumatism, 2000
- Changes in messenger rna and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samplesArthritis & Rheumatism, 1997
- Activation of fibrillar collagen synthesis and phenotypic modulation of chondrocytes in early human osteoarthritic cartilage lesionsOsteoarthritis and Cartilage, 1997
- Discoordinate gene expression of aggrecan and type ii collagen in experimental osteoarthritisArthritis & Rheumatism, 1995
- Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesisOsteoarthritis and Cartilage, 1993
- Collagen family of proteinsThe FASEB Journal, 1991
- In Vivo and in Vitro Stimulation of Chondrocyte Biosynthetic Activity in Early Experimental OsteoarthritisArthritis & Rheumatism, 1984
- Demonstration of increased proteoglycan turnover in cartilage explants from dogs with experimental osteoarthritisJournal of Orthopaedic Research, 1984
- Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosisBiochemical Journal, 1980
- Biochemical and Metabolic Abnormalities in Articular Cartilage from Osteo-Arthritic Human HipsJournal of Bone and Joint Surgery, 1971